Form 483

FORMULATION INNOVATIONS GROUP Form 483, 2026-04-02

FDA issued a Form 483 to FORMULATION INNOVATIONS GROUP on 2026-04-02 with 4 public-safe observations.

483· Form 483 issuedFoods & Cosmetics4 observations

FORMULATION INNOVATIONS GROUP · Horsham, United States · Issued April 2, 2026

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Apr 2026
21 CFR 111.205(a)

Master manufacturing record - prepared

Cited by Yessika Mashinski

2 Apr 2026
21 CFR 111.260

Batch record - required information

Cited by Yessika Mashinski

2 Apr 2026
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Yessika Mashinski

2 Apr 2026
21 CFR 111.75(c)

Specifications met - verify; finished batch

Cited by Yessika Mashinski

Inspected site

FIFORMULATION INNOVATIONS GROUPHorsham, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.260Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere